Yunding Xinyao (01952.HK) and Hainan Herui reached a commercial cooperation on budesonide enteric capsules.

Translated to Wisdom Financial News APP News, YunDing XinYao (01952.HK) has announced that the company has reached a commercial cooperation with Hainan Herui Pharmaceutical Co., Ltd. (Hainan Herui) on the commercialization of their Budesonide Enteric Capsules in Hainan and Rui. The product was approved by the National Medical Products Administration (NMPA) in December 2025.